These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11747276)

  • 61. [The influence of the hemoglobin concentration on the hematogenous tumor cell dissemination at the time of the initial diagnosis of breast cancer].
    Janni W; Strobl B; Rack B; Rjosk D; Schindlbeck C; Hantschmann P; Kentenich C; Sigg W; Zerzer M; Sommer H
    Dtsch Med Wochenschr; 2002 Jan; 127(3):71-7. PubMed ID: 11797143
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up.
    Harbeck N; Untch M; Pache L; Eiermann W
    Br J Cancer; 1994 Mar; 69(3):566-71. PubMed ID: 7510120
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The clinical significance of disseminated tumor cells in breast cancer.
    Slade MJ; Coombes RC
    Nat Clin Pract Oncol; 2007 Jan; 4(1):30-41. PubMed ID: 17183354
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A summary of two clinical studies on tumor cell dissemination in primary and metastatic breast cancer: methods, prognostic significance and implication for alternative treatment protocols (Review).
    Kasimir-Bauer S; Oberhoff C; Schindler AE; Seeber S
    Int J Oncol; 2002 May; 20(5):1027-34. PubMed ID: 11956600
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow.
    Braun S; Hepp F; Kentenich CR; Janni W; Pantel K; Riethmüller G; Willgeroth F; Sommer HL
    Clin Cancer Res; 1999 Dec; 5(12):3999-4004. PubMed ID: 10632331
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Occult micrometastasis: enrichment, identification and characterization of single disseminated tumour cells.
    Pantel K; Otte M
    Semin Cancer Biol; 2001 Oct; 11(5):327-37. PubMed ID: 11562175
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [High-dose chemotherapy with autologous peripheral blood stem cell transplantation support in a patient with breast cancer metastasis to bone marrow: immunocytochemical monitoring of cancer-cell contamination].
    Uno H; Fujita M; Hino N; Nakagawa H; Miyagawa H; Aoki J; Taniyama K; Sasaki N
    Rinsho Ketsueki; 1999 Jul; 40(7):556-62. PubMed ID: 10483138
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patients.
    Watson MA; Ylagan LR; Trinkaus KM; Gillanders WE; Naughton MJ; Weilbaecher KN; Fleming TP; Aft RL
    Clin Cancer Res; 2007 Sep; 13(17):5001-9. PubMed ID: 17785550
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prognostic relevance of urokinase plasminogen activator detection in micrometastatic cells in the bone marrow of patients with primary breast cancer.
    Solomayer EF; Diel IJ; Wallwiener D; Bode S; Meyberg G; Sillem M; Gollan C; Kramer MD; Krainick U; Bastert G
    Br J Cancer; 1997; 76(6):812-8. PubMed ID: 9310251
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immunodiagnosis and immunotherapy of isolated tumor cells disseminated to bone marrow of patients with colorectal cancer.
    Braun S; Pantel K
    Tumori; 1995; 81(3 Suppl):78-83. PubMed ID: 7571061
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Bone marrow micrometastases in breast cancer patients.
    Molino A; Pelosi G; Micciolo R; Turazza M; Nortilli R; Pavanel F; Cetto GL
    Breast Cancer Res Treat; 1999 Nov; 58(2):123-30. PubMed ID: 10674876
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Micrometastases: marker of metastatic potential or evidence of residual disease?
    O'Sullivan GC; Collins JK; Kelly J; Morgan J; Madden M; Shanahan F
    Gut; 1997 Apr; 40(4):512-5. PubMed ID: 9176080
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Detection of occult metastases in lung carcinomas: progress and implications for lung cancer staging.
    Cote RJ; Hawes D; Chaiwun B; Beattie EJ
    J Surg Oncol; 1998 Dec; 69(4):265-74. PubMed ID: 9881945
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas.
    Schindlbeck C; Kampik T; Janni W; Rack B; Jeschke U; Krajewski S; Sommer H; Friese K
    Breast Cancer Res; 2005; 7(6):R1174-85. PubMed ID: 16457698
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators.
    Hofmann T; Riesenberg R; Buchner A; Zimmermann W; Hofstetter A; Oberneder R
    J Urol; 2003 Apr; 169(4):1303-7. PubMed ID: 12629348
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A pooled analysis of bone marrow micrometastasis in breast cancer.
    Braun S; Vogl FD; Naume B; Janni W; Osborne MP; Coombes RC; Schlimok G; Diel IJ; Gerber B; Gebauer G; Pierga JY; Marth C; Oruzio D; Wiedswang G; Solomayer EF; Kundt G; Strobl B; Fehm T; Wong GY; Bliss J; Vincent-Salomon A; Pantel K
    N Engl J Med; 2005 Aug; 353(8):793-802. PubMed ID: 16120859
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Non-specifically labelled cells that simulate bone marrow metastases in patients with non-metastatic breast cancer.
    Lagrange M; Ferrero JM; Lagrange JL; Machiavello JC; Monticelli J; Bayle C; Creisson A; Namer M; Thyss A; Bourcier C; Gioanni J; Schneider M
    J Clin Pathol; 1997 Mar; 50(3):206-11. PubMed ID: 9155670
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sensitive fluorescent in situ hybridisation method for the characterisation of breast cancer cells in bone marrow aspirates.
    Forus A; Høifødt HK; Overli GE; Myklebost O; Fodstad O
    Mol Pathol; 1999 Apr; 52(2):68-74. PubMed ID: 10474684
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bone marrow "micrometastases" of epithelial tumors: detection and clinical relevance.
    Müller P; Schlimok G
    J Cancer Res Clin Oncol; 2000 Nov; 126(11):607-18. PubMed ID: 11079724
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Occult tumor cells in bone marrow of patients with locoregionally restricted ovarian cancer predict early distant metastatic relapse.
    Braun S; Schindlbeck C; Hepp F; Janni W; Kentenich C; Riethmüller G; Pantel K
    J Clin Oncol; 2001 Jan; 19(2):368-75. PubMed ID: 11208828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.